Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
Identifieur interne : 000318 ( Main/Merge ); précédent : 000317; suivant : 000319Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
Auteurs : Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 2017.
Descripteurs français
- KwdFr :
- Animaux, Femelle, Grippe humaine (), Grippe humaine (anatomopathologie), Humains, Immunité humorale, Modèles animaux de maladie humaine, Pandémies (), Souris de lignée BALB C, Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Vaccins antigrippaux (isolement et purification), Vaccins inactivés (administration et posologie), Vaccins inactivés (immunologie), Vaccins inactivés (isolement et purification), Virus de la grippe A (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux, Vaccins inactivés.
- anatomopathologie : Grippe humaine.
- immunologie : Vaccins antigrippaux, Vaccins inactivés, Virus de la grippe A.
- isolement et purification : Vaccins antigrippaux, Vaccins inactivés.
- Animaux, Femelle, Grippe humaine, Humains, Immunité humorale, Modèles animaux de maladie humaine, Pandémies, Souris de lignée BALB C.
English descriptors
- KwdEn :
- Animals, Disease Models, Animal, Female, Humans, Immunity, Humoral, Influenza A virus (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza Vaccines (isolation & purification), Influenza, Human (pathology), Influenza, Human (prevention & control), Mice, Inbred BALB C, Pandemics (prevention & control), Vaccines, Inactivated (administration & dosage), Vaccines, Inactivated (immunology), Vaccines, Inactivated (isolation & purification).
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Vaccines, Inactivated.
- immunology : Influenza A virus, Influenza Vaccines, Vaccines, Inactivated.
- chemical , isolation & purification : Influenza Vaccines, Vaccines, Inactivated.
- pathology : Influenza, Human.
- prevention & control : Influenza, Human, Pandemics.
- Animals, Disease Models, Animal, Female, Humans, Immunity, Humoral, Mice, Inbred BALB C.
Abstract
Subtype H2 Influenza A viruses were the cause of a severe pandemic in the winter of 1957. However, this subtype no longer circulates in humans and is no longer included in seasonal vaccines. As a result, individuals under 50 years of age are immunologically naïve. H2 viruses persist in aquatic birds, which were a contributing source for the 1957 pandemic, and have also been isolated from swine. Reintroduction of the H2 via zoonotic transmission has been identified as a pandemic risk, so pre-pandemic planning should include preparation and testing of vaccine candidates against this subtype. We evaluated the immunogenicity of two inactivated, whole virus influenza vaccines (IVV) in mice: a monovalent IVV containing human pandemic virus A/Singapore/1/1957 (H2N2), and a multivalent IVV containing human A/Singapore/1/1957, avian A/Duck/HongKong/319/1978 (H2N2), and swine A/Swine/Missouri/2124514/2006 (H2N3) viruses. While both vaccines induced protective immunity compared to naïve animals, the
Url:
DOI: 10.1016/j.vaccine.2017.01.026
PubMed: 28189402
PubMed Central: 5336516
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000859
- to stream Pmc, to step Curation: 000859
- to stream Pmc, to step Checkpoint: 000238
- to stream PubMed, to step Corpus: 000039
- to stream PubMed, to step Curation: 000039
- to stream PubMed, to step Checkpoint: 000036
- to stream Ncbi, to step Merge: 000D47
- to stream Ncbi, to step Curation: 000D47
- to stream Ncbi, to step Checkpoint: 000D47
Links to Exploration step
PMC:5336516Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice</title>
<author><name sortKey="Lenny, Brian J" sort="Lenny, Brian J" uniqKey="Lenny B" first="Brian J." last="Lenny">Brian J. Lenny</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Biology, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Biology, Rhodes College, 2000 North Parkway, Memphis, TN 38112</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sonnberg, Stephanie" sort="Sonnberg, Stephanie" uniqKey="Sonnberg S" first="Stephanie" last="Sonnberg">Stephanie Sonnberg</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Danner, Angela F" sort="Danner, Angela F" uniqKey="Danner A" first="Angela F." last="Danner">Angela F. Danner</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Friedman, Kimberly" sort="Friedman, Kimberly" uniqKey="Friedman K" first="Kimberly" last="Friedman">Kimberly Friedman</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J." last="Webby">Richard J. Webby</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webster, Robert G" sort="Webster, Robert G" uniqKey="Webster R" first="Robert G." last="Webster">Robert G. Webster</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jones, Jeremy C" sort="Jones, Jeremy C" uniqKey="Jones J" first="Jeremy C." last="Jones">Jeremy C. Jones</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">28189402</idno>
<idno type="pmc">5336516</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336516</idno>
<idno type="RBID">PMC:5336516</idno>
<idno type="doi">10.1016/j.vaccine.2017.01.026</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000859</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000859</idno>
<idno type="wicri:Area/Pmc/Curation">000859</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000859</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000238</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000238</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:28189402</idno>
<idno type="wicri:Area/PubMed/Corpus">000039</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000039</idno>
<idno type="wicri:Area/PubMed/Curation">000039</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000039</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000036</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000036</idno>
<idno type="wicri:Area/Ncbi/Merge">000D47</idno>
<idno type="wicri:Area/Ncbi/Curation">000D47</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D47</idno>
<idno type="wicri:doubleKey">0264-410X:2017:Lenny B:evaluation:of:multivalent</idno>
<idno type="wicri:Area/Main/Merge">000318</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice</title>
<author><name sortKey="Lenny, Brian J" sort="Lenny, Brian J" uniqKey="Lenny B" first="Brian J." last="Lenny">Brian J. Lenny</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2"> Department of Biology, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Biology, Rhodes College, 2000 North Parkway, Memphis, TN 38112</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sonnberg, Stephanie" sort="Sonnberg, Stephanie" uniqKey="Sonnberg S" first="Stephanie" last="Sonnberg">Stephanie Sonnberg</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Danner, Angela F" sort="Danner, Angela F" uniqKey="Danner A" first="Angela F." last="Danner">Angela F. Danner</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Friedman, Kimberly" sort="Friedman, Kimberly" uniqKey="Friedman K" first="Kimberly" last="Friedman">Kimberly Friedman</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J." last="Webby">Richard J. Webby</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webster, Robert G" sort="Webster, Robert G" uniqKey="Webster R" first="Robert G." last="Webster">Robert G. Webster</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jones, Jeremy C" sort="Jones, Jeremy C" uniqKey="Jones J" first="Jeremy C." last="Jones">Jeremy C. Jones</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<idno type="eISSN">1873-2518</idno>
<imprint><date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Humans</term>
<term>Immunity, Humoral</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza Vaccines (isolation & purification)</term>
<term>Influenza, Human (pathology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Mice, Inbred BALB C</term>
<term>Pandemics (prevention & control)</term>
<term>Vaccines, Inactivated (administration & dosage)</term>
<term>Vaccines, Inactivated (immunology)</term>
<term>Vaccines, Inactivated (isolation & purification)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (anatomopathologie)</term>
<term>Humains</term>
<term>Immunité humorale</term>
<term>Modèles animaux de maladie humaine</term>
<term>Pandémies ()</term>
<term>Souris de lignée BALB C</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins antigrippaux (isolement et purification)</term>
<term>Vaccins inactivés (administration et posologie)</term>
<term>Vaccins inactivés (immunologie)</term>
<term>Vaccins inactivés (isolement et purification)</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
<term>Vaccines, Inactivated</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
<term>Vaccins inactivés</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
<term>Vaccins inactivés</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
<term>Influenza Vaccines</term>
<term>Vaccines, Inactivated</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Influenza Vaccines</term>
<term>Vaccines, Inactivated</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Vaccins antigrippaux</term>
<term>Vaccins inactivés</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Humans</term>
<term>Immunity, Humoral</term>
<term>Mice, Inbred BALB C</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Immunité humorale</term>
<term>Modèles animaux de maladie humaine</term>
<term>Pandémies</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P2">Subtype H2 Influenza A viruses were the cause of a severe pandemic in the winter of 1957. However, this subtype no longer circulates in humans and is no longer included in seasonal vaccines. As a result, individuals under 50 years of age are immunologically naïve. H2 viruses persist in aquatic birds, which were a contributing source for the 1957 pandemic, and have also been isolated from swine. Reintroduction of the H2 via zoonotic transmission has been identified as a pandemic risk, so pre-pandemic planning should include preparation and testing of vaccine candidates against this subtype. We evaluated the immunogenicity of two inactivated, whole virus influenza vaccines (IVV) in mice: a monovalent IVV containing human pandemic virus A/Singapore/1/1957 (H2N2), and a multivalent IVV containing human A/Singapore/1/1957, avian A/Duck/HongKong/319/1978 (H2N2), and swine A/Swine/Missouri/2124514/2006 (H2N3) viruses. While both vaccines induced protective immunity compared to naïve animals, the <bold>multivalent</bold>
formulation was advantageous over the monovalent in terms of level and breadth of serological responses, <bold>neutralization of infectious virus</bold>
, and reduction of clinical disease and respiratory tissue replication in mice. Therefore, <bold>multivalent</bold>
pandemic H2 vaccines containing diverse viruses from animal reservoirs, are a potential option to improve the immune responses in a pre-pandemic scenario where antigenic identity cannot be predicted.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000318 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000318 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Merge |type= RBID |clé= PMC:5336516 |texte= Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:28189402" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
This area was generated with Dilib version V0.6.33. |